Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer. Huang LT, Zhang SL, Han CB, Ma JT, et al. Lung Cancer 2022;166:9-16.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang LT, Zhang SL, Han CB, Ma JT, et al. Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer. Lung Cancer 2022;166:9-16.
PMID: 35151115